BF Biosciences inks deal with Lucky Core

MG News | September 04, 2024 at 10:30 AM GMT+05:00

Add Mettisglobal as a Trusted Source on Google

0:00

September 04, 2024 (MLN): BF Biosciences Limited (BFBL)has entered into a contract manufacturing and supply agreement with Lucky Core Industries Limited (LCI) for the products "Esopase IV 40 mg" & "Etipro IV 40 mg", the company's filing on PSX revealed.

BFBL is a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ).

In August, BF Biosciences successfully launched human insulin under the brand name "Ferulin".

BF Biosciences was established exclusively for the manufacture of biologicals and it is the first and only company in Pakistan currently to have a biotech manufacturing facility.

Copyright Mettis Link News

Related News

Integrated Equities seeks PSX listing through Rs7/share IPO

SECP initiates action over SE Fruits IPO discrepancies

PSX Closing Bell: Little Gains, Longer Streak

Name	Price/Vol	%Chg/NChg
KSE100	166,419.72 133.15M	0.14% 233.55
ALLSHR	100,871.92 395.66M	0.05% 48.64
KSE30	49,316.65 59.50M	0.05% 23.11
KMI30	239,907.60 63.28M	-0.05% -114.34
KMIALLSHR	65,473.69 245.25M	-0.00% -2.07
BKTi	45,849.28 9.86M	0.23% 104.46
OGTi	33,523.02 3.37M	-0.51% -171.71

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	81,125.00	82,995.00 80,805.00	-1305.00 -1.58%
BRENT CRUDE	109.76	110.00 104.91	3.84 3.63%
RICHARDS BAY COAL MONTHLY	128.50	0.00 0.00	0.05 0.04%
ROTTERDAM COAL MONTHLY	145.10	0.00 0.00	0.15 0.10%
USD RBD PALM OLEIN	1,167.50	1,167.50 1,167.50	0.00 0.00%
CRUDE OIL - WTI	99.13	99.34 95.29	2.63 2.73%
SUGAR #11 WORLD	20.85	21.01 20.47	-0.28 -1.33%